Autonomix Medical, Inc.
News
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients
Globe Newswire Autonomix Medical, Inc.\n\n Image 1\n\n Autonomix Medical, Inc.\n\n Image 2\n\n Autonomix Medical, Inc.\n\n Image 3\n\nResponders experienced a pain...\n more…
Autonomix Medical (NASDAQ:AMIX) Now Covered by Analysts at LADENBURG THALM/SH SH
Ticker Report LADENBURG THALM/SH SH assumed coverage on shares of Autonomix Medical (NASDAQ:AMIX - Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The firm issued a buy rating and...\n more…
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire THE WOODLANDS, TX, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ( Autonomix or the Company ), a medical device company focused on advancing innovative technologies to...\n more…
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress
Globe Newswire Presentation to discuss latest developments in future AI applications in interventional radiology, specifically highlighting the early results from the Company's ongoing proof-of-concept (PoC) human...\n more…
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones
Globe Newswire First-in-class catheter-based sensing and ablation technology that targets neural signals that indicate pain or disease and destroys them at the source Positive 7-day topline results from...\n more…